IN SILICO STUDY OF MIRNA-REGULATED IQ MOTIF-CONTAINING GTPASE-ACTIVATING PROTEIN FAMILY IN LIVER CANCER
Objective: The aim of this paper is to identify the list of microRNA (miRNA) which can regulate the aberrant expression of IQGAP in liver cancer formation. The aberrant expression of IQ motif-containing GTPase-activating protein (IQGAP) family which consists of IQGAP1, IQGAP2, and IQGAP3 has been linked to carcinogenesis in human cancers. The reciprocal expression of IQGAP family in human cancer has been studied to act as oncogenes or tumor suppressor genes. A growing number of studies suggest that upregulated or downregulated expression of IQGAP family triggers cancer development.
Methods: A correlation study was performed to construct a pathway to inhibit or activate IQGAP family between miRNAs and IQGAPs. A pre-processing step was conducted to download, filter and process the dataset from TCGA. It yields miRNA and IQGAP gene expression matrix. Then, correlation computation was computed using MATLAB. Moreover, this study linked the results to the MiRTarBase to validate the prediction result with the wet lab experimental result.
Results: This study identified significantly inversely correlation in 51 miRNAs-IQGAP1, 169 miRNAs-IQGAP2, and 33 miRNAs-IQGAP3, respectively, which may potentially play a role in a liver cancer formation. Some of the results also can be found in miRTarBase. It supports the precision of those miRNA and IQGAP interaction between dry lab and wet lab study. IQGAP1 and IQGAP2 mostly has been identified as an oncogene in cancer but IQGAP2 has been discovered as tumor suppressor gene. The list of miRNA in the result of this study can become a potential therapy to target the aberrant expression of IQGAP family.
Conclusion: miRNA function is known as an oncogene or tumor suppressor gene in cancer development. Therefore, it can be one of the important molecular biology which may target the aberrant expression of IQGAP in liver cancer.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
3. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-46.
4. Briggs MW, Sacks DB. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep 2003;4:571-4.
5. Johnson M, Sharma M, Henderson BR. IQGAP1 regulation and roles in cancer. Cell Signal 2009;21:1471-8.
6. White CD, Brown MD, Sacks DB. IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesis. FEBS Lett 2009;583:1817-24.
7. Chen F, Zhu HH, Zhou LF, Wu SS, Wang J, Chen Z, et al. IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by akt activation. Exp Mol Med 2010;42:477-83.
8. Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y, et al. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int J Cancer 2008;122:1040-6.
9. Zeng H, Yu H, Lu L, Jain D, Kidd MS, Saif MW, et al. Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Pancreas 2011;40:657-63.
10. Huang L, Xu S, Hu D, Lu W, Xie X, Cheng X, et al. IQGAP1 is involved in enhanced aggressive behavior of epithelial ovarian cancer stem cell-like cells during differentiation. Int J Gynecol Cancer 2015;25:559-65.
11. Wang XX, Wang K, Li XZ, Zhai LQ, Qu CX, Zhao Y, et al. Targeted knockdown of IQGAP1 inhibits the progression of esophageal squamous cell carcinoma in vitro and in vivo. PLoS One 2014;9:e96501.
12. Xia FD, Wang ZL, Chen HX, Huang Y, Li JD, Wang ZM, et al. Differential expression of IQGAP1/2 in hepatocellular carcinoma and its relationship with clinical outcomes. Asian Pac J Cancer Prev 2014;15:4951-6.
13. Xie Y, Yan J, Cutz JC, Rybak AP, He L, Wei F, et al. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis. Biochim Biophys Acta 2012;1822:875-84.
14. Xu W, Xu B, Yao Y, Yu X, Cao H, Zhang J, et al. Overexpression and biological function of IQGAP3 in human pancreatic cancer. Am J Transl Res 2016;8:5421-32.
15. Casteel DE, Turner S, Schwappacher R, Rangaswami H, Su-Yuo J, Zhuang S, et al. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration. J Biol Chem 2012;287:38367-78.
16. Cui X, Song L, Bai Y, Wang Y, Wang B, Wang W, et al. Elevated IQGAP1 and CDC42 levels correlate with tumor malignancy of human glioma. Oncol Rep 2017;37:768-76.
17. BessÃ¨de E, Molina S, AcuÃ±a-Amador L, Dubus P, Staedel C, Chambonnier L, et al. Deletion of IQGAP1 promotes helicobacter pylori-induced gastric dysplasia in mice and acquisition of cancer stem cell properties in vitro. Oncotarget 2016;7:80688-99.
18. Su D, Liu Y, Song T. Knockdown of IQGAP1 inhibits proliferation and epithelial-mesenchymal transition by wnt/Î²-catenin pathway in thyroid cancer. Onco Targets Ther 2017;10:1549-59.
19. Kumar D, Hassan MK, Pattnaik N, Mohapatra N, Dixit M. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers. PLoS One 2017;12:e0186977.
20. Liang Z, Yang Y, He Y, Yang P, Wang X, He G, et al. SUMOylation of IQGAP1 promotes the development of colorectal cancer. Cancer Lett 2017;411:90-9.
21. Oom AL, Humphries BA, Yang C. MicroRNAs: Novel players in cancer diagnosis and therapies. BioMed Res Int 2014;2014:959461.
22. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, et al. MiRTarBase: A database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 2011;39:D163-9.
23. Agustriawan D, Huang CH, Sheu JJ, Lee SC, Tsai JJP, Kurubanjerdjit N, et al. DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis. Comput Biol Chem 2016;65:154-64.